Search PubMed⌕ Search

Biomedical subjects

C Weiss

Publications and source records attributed to C Weiss.

At least 343 records · Page 19Linked to original sources
PubMed1966

On the proposed energy switch in photosynthesis.

This paper analyzes the "energy switch" that has often been proposed to direct quanta absorbed by a given photosynthetic unit alternately to the site of one and then the other primary reaction. Such a device is essential to the Franck-Rosenberg theory, but not to the Duysens-Witt-Kok (DWK) model, which needs to assume only that the reactions occur in series. If there is no energy switch, an incident quantum absorbed at any time by any particular pigment molecule stands a chance of ending up in the reactive site of either primary reaction. The "separate packages" model is a special case of this general picture. Without an energy switch, a series model requires a storage device to insure that a quantum will not be wasted if it arrives at the site of one reaction while the photosynthetic unit is set up to perform the other. Such a storage device can be appended to the DWK model. Alternatively, this model can be augmented by an energy switch. This gives what is commonly known as the "spillover model," a confusing name which we suggest be abandoned. As a clear-cut-though perhaps technically unfeasible-test of the energy switch hypothesis, we imagine a quantum injector, a hypothetical source of flashing light which delivers a single quantum to every photosynthetic unit with each flash. We aim this useful figment at an (equally hypothetical) photosynthetic system all of whose units are set up to perform the same primary reaction. If there is an energy switch, we can now prepare a "synchronous" photosynthetic apparatus in which each photosynthetic unit is undergoing the same reaction at the same time.

Electron Transport↗
PubMedDate not supplied

Influence of different doses of interferon-alpha-2b on the blood plasma levels of 5-fluorouracil.

The blood plasma levels of 5-fluorouracil (5FU) after i.v. administration have been determined without and under the influence of 1, 5 or 9 million units (MU) preadministered interferon (IFN) in patients with gastrointestinal carcinoma. The co-administration of 9 MU IFN causes a doubled increase of the 5FU serum concentrations combined with a statistically significant change of the pharmacokinetics of 5FU for c0, AUC, Vd and Cltot (P < 0.005). A similar effect with distinctly increased serum concentrations could be observed for the preadministration of 5 mU IFN whereby c0 and AUC were elevated significantly (P < 0.05), but not Vd, Cltot and cd. The preadministration of 1 MU IFN also leads to higher plasma levels, but no changes in the pharmacokinetics of 5FU could be calculated (P > 0.05). A linear correlation between the IFN dose and the pharmacokinetic parameters c0 (R = 0.958), AUC0-120 (R = 0.948), Vd (R = 0.941) and Cltot (R = 0.963) of 5FU could be found (P < 0.05), but not for the coefficient of distribution and t1/2el. The results indicate that the pharmacokinetics of 5FU might be influenced by the preadministered IFN dose.

Aged↗
PubMedDate not supplied

Pharmacokinetics of pirazolac--a new anti-inflammatory drug--in human volunteers. I. Absorption, disposition, biotransformation and excretion.

The absorption, disposition, biotransformation and excretion of the nonsteroidal anti-inflammatory drug pirazolac were investigated in 6 volunteers (3 males, 3 females, age 50 greater than years) after intravenous and oral administration of 50 mg 14C-pirazolac as an aqueous solution of the sodium salt. Pirazolac was very rapidly and completely absorbed and bioavailable when orally administered in a dose of 50 mg in solution. Maximum pirazolac levels in plasma of 6 micrograms/ml (30% of dose in total plasma volume) were already reached after approx. 20 minutes. No metabolites were detectable in the plasma. Pirazolac was eliminated from the plasma in two phases with half-lives of 3 hours and 16 hours, respectively, regardless of administration route. After intravenous and oral administration approximately 80% of the dose was excreted with the urine and approximately 15% with the feces within 7 days, indicating a complete excretion of 14C-radioactivity. In urine, approximately 10% of the dose was identified as unchanged pirazolac and 70% as pirazolac ester glucuronide.

Administration, Oral↗
PubMedDate not supplied

Disposition of 5-formyl- and 5-methyltetrahydrofolic acid in serum after i.v. bolus of calcium folinate: pharmacokinetic drug interaction with preadministered interferon-alpha-2b.

The influence of interferon (IFN) coadministered subcutaneously with the biomodulating agent folinic acid on the blood serum levels of 5-formyl-tetrahydrofolic acid (CHO-THFA) and the biotransformation into its main metabolite in the blood 5-methyltetrahydrofolic acid (CH3-THFA) was studied in patients receiving a chemotherapy with 5-fluorouracil. IFN causes a clear decrease of the serum concentrations of CHO-THFA and a statistically significant decrease of CH3-THFA concentrations (P < 0.01). The effect on serum concentrations could be observed in each patient, but in a different order of magnitude. As a consequence, the preadministration of IFN leads to a significant change in the basic pharmacokinetic parameters of both compounds: the mean area under the concentration-time curve is decreased at 27.4% for CHO-THFA (P < 0.025) and at 22.4% for CH3-THFA (P < 0.025), respectively. The total body clearance is elevated at 45.4% for CHO-THFA (P < 0.05) and at 23.4% for CH3-THFA (P < 0.05). The mean volume of distribution is increased by IFN at 38.2% for CHO-THFA (P < 0.025) and at 22.3% for CH3-THFA (P < 0.05). The nearly identical mean residence time in both groups indicates that CHO-THFA elimination is not affected by IFN. But the results prove a certain interaction between IFN and CHO-THFA. IFN accelerates the distribution of CHO-THFA as well as of its main metabolite from the blood into the tissue or activates the biotransformation of CHO-THFA into CH3-THFA inside the cells of the tissue. The extent of biotransformation of CHO-THFA into CH3-THFA, which takes place in the blood, is not influenced by IFN because percentage AUC-ratios CHO-THFA:CH3-THFA were 89.5:10.5% for the control group and 88.8:11.2% for the IFN group.

Aged↗
PubMedDate not supplied

The effects of age on eyeblink conditioning in the freely moving Fischer-344 rat.

The effects of age were assessed on the ability of male Fischer-344 rats to acquire a classically conditioned eyeblink using the "delay" paradigm. Using a 350 ms white noise conditioning stimulus and a 100 ms coterminating periorbital shock (2 mA, 60 Hz, AC) we have demonstrated that these rats exhibit deficits as early as middle age. Middle-aged and senescent rats (18 and 30 months) exhibited significantly fewer conditioned responses than young rats (3 and 12 months). Since all of the rats responded to a test noise, and there were no differences in threshold to evoke a blink, this result is likely to be due to an associative deficit. Thus, our results indicate that eyeblink conditioning in the freely moving rat is a useful model system for behavioral and neurobiological analyses of the effects of age on associative learning and memory.

Aging↗
PubMedDate not supplied

Delayed acquisition of eyeblink conditioning in aged F1 hybrid (Fischer-344 x Brown Norway) rats.

We previously reported that the freely moving male Fischer-344 rat provides a useful model to demonstrate the progressive impairment of eyeblink conditioning associated with aging. However, because the youngest F-344 rats only performed at 60% of maximum, we ran the same experiment with hybrid rats and discovered most (i.e., those age 9-24 months) learned rapidly and exhibited conditioned responses on greater than 80% of trials by the end of two training sessions. In contrast, the aged rats (36 months) exhibited significantly fewer CRs on all four training days. However, unlike all ages of F-344 rats (3-30 months) which were run in our last study, these aged hybrid rats exhibited considerable improvement with extra training. These data indicate clear differences in the rate of learning between the two strains and suggest that even young F-344 rats may have deficits in the neural circuits which mediate eyeblink conditioning. Other anecdotal findings on differences between the two strains are noted.

Aging↗
PubMedDate not supplied

Age-related effects on eyeblink conditioning in the F344 x BN F1 hybrid rat.

Young, middle-aged, old, and senescent Fischer 344 x Brown Norway F1 hybrid rats were trained in either the trace or delay eyeblink conditioning task in order to investigate how aging affects associative learning and memory over the life span. Senescent rats at 34-35 months showed severe impairments in acquisition of the trace task with a 250 msec trace interval, which is hippocampally-dependent, and were mildly impaired in the simple delay eyeblink conditioning task. Middle aged animals, varying in age from 18-24 months, acquired the trace and delay eyeblink paradigms as well as young rats (6 months). However, at 28-29 months, approximately 50% of the old animals showed impairments in the trace 250 msec eyeblink task. Our results show that trace eyeblink conditioning is an age-sensitive task useful for studying the neural substrates underlying associative learning and memory in rats, as has been previously shown in humans and rabbits.

Age Factors↗